Advertisement
| cardiotoxic drugs ppt: Cardiotoxicity Wenyong Tan, 2018-11-14 Cardiotoxicity may be caused by radiotherapy and/or anticancer agents for many malignancies, adverse effects of some drugs in the context of medical intervention or heavy metal intake, especially during the anticancer therapy. This book intends to bring forward the recent development in toxicities from cancer treatment. It updates the possible mechanisms of cardiotoxicities of some anticancer agents and the suggested prevention and treatment strategies. This book contains many valuable contributions from the researchers in oncology and cardiology as well as the clinicians who are experts in this field. |
| cardiotoxic drugs ppt: Medicinal Chemistry of Anticancer Drugs Carmen Avendaño, J. Carlos Menéndez, 2023-04-28 This third edition of Medicinal Chemistry of Anticancer Drugs, provides an updated resource for students and researchers from the point of view of medicinal chemistry and drug design, focusing on the mechanism of action of antitumor drugs from the molecular level, and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents. Antitumor chemotherapy is a very active field of research, and a huge amount of information on the topic is generated every year. This new edition includes updated sections on the hot topic of cancer immunotherapy, cancer polypharmacology, multitargeted cancer therapy, medicinal chemistry of cancer diagnosis, theranostic anticancer agents, and pre-mRNA processing in cancer. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book provides a unique and valuable perspective from the point of view of medicinal chemistry and drug design. It will be useful to undergraduate and postgraduate students of medicinal chemistry, pharmacology, biological chemistry, pharmacy and other health sciences. Researchers and practitioners will find a comprehensive treatment of the topic and a large number of references to reviews and the primary literature. - Provides a resource that is organized consistently based on targets and mechanisms of action from a molecular point-of-view - Focuses on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents, providing a rationalization on the action of these type of drugs and the design of new active structures - Features a large number of color figures which give information in a clear-and-concise way - Includes extensive references to review articles and primary literature - Includes updated sections on the hot topic of cancer immunotherapy, cancer polypharmacology, multitargeted cancer therapy, medicinal chemistry of cancer diagnosis, theragnostic anticancer agents, and pre-mRNA processing in cancer |
| cardiotoxic drugs ppt: Cardioprotection Derek Hausenloy, Derek Yellon, 2009-08-20 Coronary heart disease (CHD) is the leading cause of death worldwide with 3.8 million men and 3.4 million women dying each year. Cardioprotection refers to the prevention of CHD and the clinical improvement in patients suffering from cardiovascular problems. This book focuses on the role of cardioprotection in surgery and the use of pharmacological therapies such as ACE-inhibitors, statins and beta-blockers in order to reduce the myocardial injury sustained by the patient and thesignificant risk of morbidity and mortality. It includes new cardioprotective strategies aimed at improving the clinical outcomes of patients in these settings, as well as current well-established methods for reducing myocardial injury in acute coronary syndrome patients. |
| cardiotoxic drugs ppt: Massachusetts General Hospital Comprehensive Clinical Psychiatry Theodore A. Stern, Maurizio Fava, Timothy E. Wilens, Jerrold F. Rosenbaum, 2015-04-09 The Massachusetts General Hospital is widely respected as one of the world's premier psychiatric institutions. Now, preeminent authorities from MGH present the newly updated edition of Massachusetts General Hospital Comprehensive Clinical Psychiatry, a unique medical reference book that continues to simplify your access to the current clinical knowledge you need - both in print and online! It provides practical approaches to a wide variety of clinical syndromes and settings, aided by stunning graphics and hundreds of questions and answers geared to each chapter. You'll have convenient access to all the authoritative answers necessary to overcome any clinical challenge. User-friendly, highly templated organization with abundant boxed summaries, bulleted points, case histories, algorithms, references, and suggested readings. Peerless, hands-on advice from members of the esteemed MGH Department of Psychiatry helps you put today's best approaches to work for your patients. Interactive and downloadable Q&As for each chapter allow you to test your retention of the material covered. In-depth coverage of many unique areas, including Psychiatric and Substance Use Disorders in Transitioning Adolescents and Young Adults; Neuroanatomical Systems Relevant to Neuropsychiatric Disorders; Legal and Ethical Issues in Psychiatry; Military Psychiatry; and Approaches to Collaborative Care and Primary Care Psychiatry. Features full, new DSM-5 criteria; new art, tables, and key points; and new Alzheimer's Disease guidelines. Highlights recent developments in the field, such as neurotherapeutics, new psychotropics, military psychiatry, collaborative care, ensuring your knowledge is thoroughly up to date. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices. |
| cardiotoxic drugs ppt: Pharmacotherapy of Heart Failure S. K. Gupta, 2005 Heart failure has been traditionally explained as a reduction in cardiac pumping capacity, caused by problems in the blood. Till now the therapy prescribed has been symptomatic, involving the use of diuretics, muscular stimulation and blood vessel relaxants. But recent research has focussed on the circumstances leading up to heart failure, which includes abnormal hemodynamics, atherosclerosis, dietary and nutritional anomalies, obesity, immunity and other metabolic disorders. This book brings together such research in one volume, including molecular and cellular aspects of heart failure and its pathophysiology. It is a significant contribution to the understanding and prevention of heart failure, and will be welcomed by cardiologists, pharmacologists, biochemists, and all those who practice and research the subject. The contributors from around the world include Australia, Brazil, Canada, Denmark, India, and USA. |
| cardiotoxic drugs ppt: The ESC Textbook of Cardiovascular Medicine A. John Camm, 2019 |
| cardiotoxic drugs ppt: Electrocardiogram in Clinical Medicine Michael J. Lipinski, Andrew E. Darby, Michael C. Bond, Nathan P. Charlton, Korin B. Hudson, Kelly Williamson, 2020-12-07 Offers a guide for a complete understanding of the disease and conditions most frequently revealed in ECGs recorded in the acute, critical, and emergency care settings Electrocardiogram in Clinical Medicine offers an authoritative guide to ECG interpretation that contains a focus and perspective from each of the three primary areas of medical care: acute care, critical care and emergency care. It can be used as a companion with the book ECGs for the Emergency Physician I & II (by Mattu and Brady) or as a stand-alone text. These three books can be described as a cumulative EGG reference for the medical provider who uses the electrocardiogram on a regular basis. Electrocardiogram in Clinical Medicine includes sections on all primary areas of ECG interpretation and application as well as sections that highlight use, devices and strategies. The medical content covers acute coronary syndromes and all related issues, other diseases of the myocardium, morphologic syndromes, toxicology and paediatrics; dysrhythmias will also be covered in detail. This important resource: • Goes beyond pattern recognition in ECGs to offer a real understanding of the clinical syndromes evidenced in ECGs and implications for treatment • Covers the indications, advantages and pitfalls of the use of ECGs for diagnosis in all acute care settings, from EMS to ED to Critical Care • Examines the ECG in toxic, metabolic and environmental presentations; critical information for acute care clinicians who need to be able to differentiate ODs, poisoning and other environmental causes from MI or other cardiac events • Facilitates clinical decision-making Written for practicing ER, general medicine, family practice, hospitalist and ICU physicians and medical students, Electrocardiogram in Clinical Medicine is an important book for the accurate interpretation of EGG results. |
| cardiotoxic drugs ppt: Massachusetts General Hospital Comprehensive Clinical Psychiatry E-Book Theodore A. Stern, Maurizio Fava, Timothy E. Wilens, Jerrold F. Rosenbaum, 2015-02-13 The Massachusetts General Hospital is widely respected as one of the world's premier psychiatric institutions. Now, preeminent authorities from MGH present a reference that is carefully designed to simplify your access to the current clinical knowledge you need. A remarkably user-friendly organization - with abundant boxed summaries, bullet points, case histories, and algorithms - speeds you to the answers you need. In short, this brand-new reference delivers all the authoritative answers you need to overcome any clinical challenge, in a format that's easier to consult than any other source! - Peerless, hands-on advice from members of the esteemed MGH Department of Psychiatry helps you put today's best approaches to work for your patients. - The book's highly templated format - with abundant boxed overviews, bulleted points, case histories, algorithms, references, and suggested readings - enables you to locate essential information quickly. - Interactive and downloadable Q&As for each chapter allow you to test your retention of the material covered. - In-depth coverage of many unique areas, including Psychiatric and Substance Use Disorders in Transitioning Adolescents and Young Adults; Neuroanatomical Systems Relevant to Neuropsychiatric Disorders; Legal and Ethical Issues in Psychiatry; Military Psychiatry; and Approaches to Collaborative Care and Primary Care Psychiatry. - Features full, new DSM-5 criteria; new art, tables, and key points; and new Alzheimer's Disease guidelines. - Highlights recent developments in the field, such as neurotherapeutics, new psychotropics, military psychiatry, collaborative care, ensuring your knowledge is thoroughly up to date. - Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices. |
| cardiotoxic drugs ppt: Cardiac Pharmacology R. Douglas Wilkerson, 2013-10-22 Cardiac Pharmacology aims to interface basic and clinical knowledge of those interventions used or being studied for use in the treatment of heart disease. The book is divided into four major sections which address intrinsic and neural control of cardiac function, pharmacologic modification of cardiac contractility and cardiac output, the genesis and control of cardiac arrhythmias, and pharmacologic manipulation of myocardial oxygen supply and demand. The last three sections contain a chapter describing the techniques employed in the study of that particular aspect of cardiac function and its alterations by pharmacologic interventions. Cardiologists, pharmacologists, physiologists, and those interested in the area of cardiovascular medicine will find the book insightful. |
| cardiotoxic drugs ppt: Poisoning in the Modern World Ozgur Karcioglu, Banu Arslan, 2019-06-19 Over 400 years ago, Swiss alchemist and physician Paracelsus (1493-1541) cited: All substances are poisons; there is none that is not a poison. The right dose differentiates a poison from a remedy. This is often condensed to: The dose makes the poison. So, why are we overtly anxious about intoxications?In fact, poisons became a global problem with the industrial revolution. Pesticides, asbestos, occupational chemicals, air pollution, and heavy metal toxicity maintain high priority worldwide, especially in developing countries. Children between 0 and 5 years old are the most vulnerable to both acute and chronic poisonings, while older adults suffer from the chronic effects of chemicals. This book aims to raise awareness about the challenges of poisons, to help clinicians understand current issues in toxicology. |
| cardiotoxic drugs ppt: Maternal Critical Care Marc van de Velde, Helen Scholefield, Lauren A. Plante, 2013-07-04 Addresses the challenges of managing critically ill obstetric patients, with chapters authored by intensivists/anesthesiologists and obstetricians/maternal-fetal medicine specialists. |
| cardiotoxic drugs ppt: Heart and Toxins Dr. Meenakshisundaram Sundaram Ramachandran, 2014-08-12 The Heart and Toxins brings together global experts to provide the latest information and clinical trials that make the connection between genetic susceptibility, gene expression, and environmental factors in cardiovascular diseases. This unique reference, edited by renowned cardiologist Meenakshi Sundaram Ramachandran, solves the problem of managing multiple clinical cases of cardiovascular toxicity. It allows connections to be made between research, diagnosis, and treatment to avoid higher morbidity and mortality rates as a result of cardiovascular toxicity. - Structured to bring together exploration into the epidemiology, molecular mechanism, pathogenesis, environmental factors and management in cardiovascular toxins - Included various topics on cardiovascular toxins such as plant, chemical, animal, nanomaterial and marine biology induced cardiac damage – which are new ideas discussed in detail - Comprehensive chapters on the cardiovascular toxicity from drugs, radiotherapy and radiological imaging - Enables you to manage multiple clinical cases of cardiovascular toxicity - Outlined conclusions at the end of each chapter providing key learning points to help you organize the chapter's details without losing insight |
| cardiotoxic drugs ppt: The EACVI Echo Handbook Patrizio Lancellotti, Bernard Cosyns, 2016 The EACVI Echo Handbook is the perfect companion for making both every day and complex clinical decisions. Designed and written by experts for use in the clinical arena, this practical guide provides the necessary information for reviewing, or consulting while performing or reporting on an echo or making clinical decisions based on echo findings. |
| cardiotoxic drugs ppt: Guidelines for the Treatment of Malaria. Third Edition World Health Organization, 2015-08-13 Malaria remains an important cause of illness and death in children and adults in countries in which it is endemic. Malaria control requires an integrated approach including prevention (primarily vector control) and prompt treatment with effective antimalarial agents. Malaria case management consisting of prompt diagnosis and effective treatment remains a vital component of malaria control and elimination strategies. Since the publication of the first edition of the Guidelines for the treatment of malaria in 2006 and the second edition in 2010 all countries in which P. falciparum malaria is endemic have progressively updated their treatment policy from use of ineffective monotherapy to the currently recommended artemisinin-based combination therapies (ACT). This has contributed substantially to current reductions in global morbidity and mortality from malaria. Unfortunately resistance to artemisinins has arisen recently in P. falciparum in South-East Asia which threatens these gains. This third edition of the WHO Guidelines for the treatment of malaria contains updated recommendations based on a firmer evidence base for most antimalarial drugs and in addition include recommendation on the use of drugs to prevent malaria in groups at high risk. The Guidelines provide a framework for designing specific detailed national treatment protocols taking into account local patterns of resistance to antimalarial drugs and health service capacity. It provides recommendations on treatment of uncomplicated and severe malaria in all age groups all endemic areas in special populations and several complex situations. In addition on the use of antimalarial drugs as preventive therapy in healthy people living in malaria-endemic areas who are high risk in order to reduce morbidity and mortality from malaria. The Guidelines are designed primarily for policy-makers in ministries of health who formulate country-specific treatment guidelines. Other groups that may find them useful include health professionals and public health and policy specialists that are partners in health or malaria control and the pharmaceutical industry. The treatment recommendations in the main document are brief; for those who wish to study the evidence base in more detail a series of annexes is provided with references to the appropriate sections of the main document. |
| cardiotoxic drugs ppt: Oxford Textbook of Critical Care Derek Angus, Simon Finfer, Luciano Gattioni, Mervyn Singer, 2019-12-03 Now in paperback, the second edition of the Oxford Textbook of Critical Care addresses all aspects of adult intensive care management. Taking a unique problem-orientated approach, this is a key resource for clinical issues in the intensive care unit. |
| cardiotoxic drugs ppt: Brain and Heart Dynamics Stefano Govoni, Pierluigi Politi, Emilio Vanoli, 2020-07-31 This ambitious and comprehensive handbook represents an essential contribution to our current understanding of interactions between heart and brain, a research topic generating growing interest. Despite the increasing awareness that neural mechanisms are the primary cause of cardiac disease and its progression, therapy continues to focus on end-organ protection and does not approach the neural core of the problem. Growing public health problems such as heart failure are still treated with autonomic drugs that are 30-40 years old and simply act on cardiac receptors. However, it has now been shown that the progression of ischemic heart disease to heart failure is mainly due to abnormal central responses to incipient cardiac disease, with neural activation the primary cause rather than the consequence of cardiac remodeling. Written by leading international experts in their respective research areas, the book presents a variety of perspectives on the core topic: from social and philosophical to gender-related aspects. It is designed for a broad readership and includes dedicated sections for cardiologists, psychiatrists, neurologists and psychotherapists looking for a more insightful and targeted approach to neuro-cardiovascular disease. |
| cardiotoxic drugs ppt: Marine Biotoxins Hans P. Egmond, Food and Agriculture Organization of the United Nations, 2004 This paper provides an extensive review of different aspects of five shellfish-poisoning syndromes (paralytic, diarrhoeic, amnesic, neurologic and azapiracid), as well as one fish-poisoning syndrome (ciguatera fish poisoning), and discusses in detail the causative toxins produced by marine organisms, chemical structures and analytical methods of the toxins, habitat and occurrence of the toxin-producing organisms, case studies and existing regulations. Based on this analysis, risk assessments are carried out for each of the toxins, and recommendations are elaborated to improve the management of these risks in order to reduce the harmful effect of these toxins on public health. |
| cardiotoxic drugs ppt: Modern Pharmacology with Clinical Applications Charles R. Craig, Robert E. Stitzel, 1997 This fifth edition of this popular title has a much greater clinical focus. The editors have added clinical cases and vignettes to drug chapters and clinical summaries closing each chapter. |
| cardiotoxic drugs ppt: Coronary Microvascular Dysfunction Filippo Crea, Gaetano A. Lanza, Paolo G. Camici, 2016-10-01 In the past two decades a number of studies have shown that abnormalities in the function and structure of coronary microcirculation can be detected in several cardiovascular diseases. On the basis of the clinical setting in which it occurs, coronary microvascular dysfunction (CMD) can be classified into four types: CMD in the absence of any other cardiac disease; CMD in myocardial diseases; CMD in obstructive epicardial coronary artery disease; and iatrogenic CMD. In some instances CMD represents an epiphenomenon, whereas in others it represents an important marker of risk or may contribute to the pathogenesis of myocardial ischemia, thus becoming a possible therapeutic target. This book provides an update on coronary physiology and a systematic assessment of microvascular abnormalities in cardiovascular diseases, in the hope that it will assist clinicians in prevention, detection and management of CMD in their everyday activity. |
| cardiotoxic drugs ppt: The Selection and Use of Essential Medicines WHO Expert Committee on the Selection and Use of Essential Medicines, 2004 This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part contains a progress report on the new procedures for updating the Model List and the development of the WHO Essential Medicines Library. It continues with a section on changes made in revising the Model List followed by a review of some sections such as hypertensive medicines and fast track procedures for deleting items. Annexes include the 13th version of the Model List and items on the list sorted according to their 5-level Anatomical Therapeutic Chemical classification codes. |
| cardiotoxic drugs ppt: Guidelines for the Treatment of Malaria World Health Organization, 2006 Malaria is an important cause of death and illness in children and adults in tropical countries, and the mortality rate (which is currently estimated at over a million people per year) has risen in recent years, probably due to increasing resistance to antimalarial medicines. Malaria control requires an integrated approach which covers both prevention (including vector control) and treatment with effective antimalarials. This publication sets out guidelines to help formulate policies and protocols for the treatment of malaria based on sound evidence that can be applied effectively in most settings. Chapters cover: treatment objectives, diagnosis of malaria, resistance to antimalarial medicines, antimalarial treatment policy, treatment of uncomplicated and severe P.falciparum malaria, treatment of P.vivax, P.ovale or P.malariae malaria, mixed malaria infections, complex emergency situations and epidemics. |
| cardiotoxic drugs ppt: Diagnosing and Treating Adult Cancers and Associated Impairments National Academies Of Sciences Engineeri, National Academies of Sciences Engineering and Medicine, Health And Medicine Division, Board On Health Care Services, Committee on Diagnosing and Treating Adult Cancers, 2021-11-10 Cancer is the second leading cause of death among adults in the United States after heart disease. However, improvements in cancer treatment and earlier detection are leading to growing numbers of cancer survivors. As the number of cancer survivors grows, there is increased interest in how cancer and its treatments may affect a person's ability to work, whether the person has maintained employment throughout the treatment or is returning to work at a previous, current, or new place of employment. Cancer-related impairments and resulting functional limitations may or may not lead to disability as defined by the U.S. Social Security Administration (SSA), however, adults surviving cancer who are unable to work because of cancer-related impairments and functional limitations may apply for disability benefits from SSA. At the request of SSA, Diagnosing and Treating Adult Cancers and Associated Impairments provides background information on breast cancer, lung cancer, and selected other cancers to assist SSA in its review of the listing of impairments for disability assessments. This report addresses several specific topics, including determining the latest standards of care as well as new technologies for understanding disease processes, treatment modalities, and the effect of cancer on a person's health and functioning, in order to inform SSA's evaluation of disability claims for adults with cancer. |
| cardiotoxic drugs ppt: Poisoning & Drug Overdose , 2004 |
| cardiotoxic drugs ppt: Anesthetic Toxicity Susan A Rice, 1994-06-30 This text is a source of information on the toxicity of anaesthetic agents. The editors define toxicity in a broad sense to mean an adverse effect, whether that effect is the result of pharmacological, toxicological, physiological, or other mechanisms. They bring together reviews by experts in the disciplines concerned - including biochemistry, gen |
| cardiotoxic drugs ppt: Principles of Safety Pharmacology Michael K. Pugsley, Michael J Curtis, 2016-10-29 This book illustrates, in a comprehensive manner, the most current areas of importance to Safety Pharmacology, a burgeoning unique pharmacological discipline with important ties to academia, industry and regulatory authorities. It provides readers with a definitive collection of topics containing essential information on the latest industry guidelines and overviews current and breakthrough topics in both functional and molecular pharmacology. An additional novelty of the book is that it constitutes academic, pharmaceutical and biotechnology perspectives for Safety Pharmacology issues. Each chapter is written by an expert in the area and includes not only a fundamental background regarding the topic but also detailed descriptions of currently accepted, validated models and methods as well as innovative methodologies used in drug discovery. |
| cardiotoxic drugs ppt: Small Animal Toxicology Essentials Robert H. Poppenga, Sharon M. Gwaltney-Brant, 2011-05-31 Providing a ready reference for the initial triage, collection of diagnostic samples, and management of a poisoning case, Small Animal Toxicology Essentials focuses on the most common poisons encountered by companion animals. From prevention to evaluation, monitoring, and treatment, the book is a guide for veterinary technicians to differentiate between significant and insignificant exposures and effectively manage animal poisonings. Emphasizing clinical signs, differential diagnoses, and case management, the book begins with the principles of veterinary toxicology, such as terminology, history-taking, and decontamination. The second half of the book is devoted to specific toxicants, including plants, metals, drugs, and household poisons. A companion website at www.wiley.com/go/poppenga provides review questions in Word and color images available for download into PowerPoint. Small Animal Toxicology Essentials is a useful resource for veterinary technicians, especially those with a interest in emergency and critical care, and veterinary technician students, as well as practicing veterinarians looking for an introduction to toxicology. |
| cardiotoxic drugs ppt: Differential Diagnosis of Chest Pain Umashankar Lakshmanadoss, 2020-07-01 This book aims to provide an excellent overview of the differential diagnosis and approach to chest pain in various clinical settings. This book is divided into two sections including the introduction and the approach to chest pain. Our introductory chapter starts with the basic principles of statistics and its application in various diagnostic modalities of heart disease. Our authors present a nice approach to patients presenting with chest pain in various scenarios. We have also included a chapter describing GERD, which could present as chest pain and another chapter describing aortic dissection, which is a life-threatening disease presenting with chest pain. We hope that this book will serve as an accessible handbook on the differential diagnosis of chest pain. |
| cardiotoxic drugs ppt: Core Topics in Preoperative Anaesthetic Assessment and Management A. Agatha Crerar-Gilbert, Mark MacGregor, 2018-04-05 Part of the popular Core Topics series, this book provides a practical guide to pre-operative assessment for consultants and trainee anaesthetists. Chapters cover comprehensive evidence-based guidance for assessing and managing patients with particular conditions, as well as perioperative risk stratification and challenges of pre-assessment. The chapters have been written by specialists in the respective clinical fields, while all content has been edited by anaesthetists to assure it is relevant and accessible to the anaesthetist in the everyday pre-operative clinic. Written specifically for anaesthetists, this resource will allow every reader to contribute effectively in a multidisciplinary approach when assessing and risk stratifying patients to ensure that they are optimised before surgery. |
| cardiotoxic drugs ppt: Essential Clinical Anesthesia Review Linda S. Aglio, Robert W. Lekowski, Richard D. Urman, 2015-01-08 This concise, evidence-based board review book, organized according to the ABA keyword list, covers all the fundamental concepts needed to pass written and re-certification board examinations. Each chapter begins with a case scenario or clinical problem from everyday practice, followed by concise discussion and clinical review questions and answers. Discussion progresses logically from preoperative assessment and intraoperative management to postoperative pain management, enhancing the reader's knowledge and honing diagnostic and clinical management skills. New guidelines and recently developed standards of care are also covered. Serving as a companion to the popular textbook Essential Clinical Anesthesia, this resourceful work reflects the clinical experiences of anesthesia experts at Harvard Medical School as well as individually known national experts in the field of anesthesiology. This practical review is an invaluable resource for anesthesiologists in training and practice, whether studying for board exams or as part of continuing education and ABA recertification. |
| cardiotoxic drugs ppt: Toxicity of Chemotherapy Michael Clinton Perry, John W. Yarbro, 1984 |
| cardiotoxic drugs ppt: Cardiomyopathy Gustav Mattsson, Peter Magnusson, 2021 Cardiomyopathies are diseases of the heart muscle with diverse etiologies ranging from myocarditis to gene mutations. They are classified according to morphology and function, and then further categorized based on whether they are familial or non-familial and based on specific etiologies. This book examines the various cardiomyopathies, including arrhythmogenic cardiomyopathy, hypertrophic cardiomyopathy, and dilated cardiomyopathy, as well as their genetic basis. |
| cardiotoxic drugs ppt: American Academy of Pediatrics Textbook of Pediatric Care Jane Meschan Foy, 2016-03-31 The definitive manual of pediatric medicine - completely updated with 75 new chapters and e-book access. |
| cardiotoxic drugs ppt: The Pericardium David H. Spodick, 1996-10-25 Presents up-to-date coverage of the pericardium in health and medical and surgical disease, integrating recent advances in understanding normal and abnormal pericardial physiology and immunology, acute and chronic pericarditis, effusion and tamponade, and imaging methods for effusion and constriction. Incorporates clinical, hemodynamic, investigative, and experimental work conducted by leading interdisciplinary researchers--including never-before-published reports--on the normal and diseased pericardium. |
| cardiotoxic drugs ppt: Hepatotoxicity Hyman J. Zimmerman, 1978 Written by the foremost authority in the field, this volume is a comprehensive review of the multifaceted phenomenon of hepatotoxicity. Dr. Zimmerman examines the interface between chemicals and the liver; the latest research in experimental hepatotoxicology; the hepatotoxic risks of household, industrial, and environmental chemicals; and the adverse effects of drugs on the liver. This thoroughly revised, updated Second Edition features a greatly expanded section on the wide variety of drugs that can cause liver injury. For quick reference, an appendix lists these medications and their associated hepatic injuries. Also included are in-depth discussions of drug metabolism and factors affecting susceptibility to liver injury. |
| cardiotoxic drugs ppt: Oncologic Critical Care Joseph L. Nates, Kristen J. Price, 2019-10-30 This major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management of the critically ill cancer patient population. Comprised of over 140 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care. Written by worldwide experts in the field, Oncologic Critical Care is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients. |
| cardiotoxic drugs ppt: Textbook of Adverse Drug Reactions David Margerison Davies, 1977 |
| cardiotoxic drugs ppt: Plant Toxins P. Gopalakrishnakone, Célia R. Carlini, Rodrigo Ligabue-Braun, |
| cardiotoxic drugs ppt: The Selection and Use of Essential Medicines World Health Organization, 2017 This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model Lists of Essential Medicines. It contains a summary of the Committee's considerations and justifications for additions and changes to the Model Lists, including its recommendations. Annexes to the main report include the revised version of the WHO Model List of Essential Medicines (20th edition) and the WHO Model List of Essential Medicines for Children (6th edition). In addition there is a list of all the items on the Model Lists sorted according to their Anatomical Therapeutic Chemical (ATC) classification codes. |
| cardiotoxic drugs ppt: Snake Venoms and Envenomations Jean-Philippe Chippaux, 2006 Presenting a synthesis of the principal discoveries on venoms and envenomations, this text describes the paleontology and classification of snakes as well as the biochemistry and toxicology of venoms to explain the theoretical basis of the envenomation and its treatment. |
| cardiotoxic drugs ppt: Plant Toxicology, Fourth Edition Bertold Hock, Erich F. Elstner, 2004-09-28 In order to keep track of all the compounds and pathogens affecting plant metabolism and development, you would need to spend all your waking hours combing periodicals and the Internet in dozens of languages, as new toxins via pollutants and migratory or mutant pathogens are being discovered every day. Plant Toxicology, Fourth Edition starts with a basic overview of the plant as a complex living organism. The first chapters introduce plant structure and organization. Starting with the cell as the smallest elementary unit, the emphasis is on plant-specific features with respect to their susceptibility to environmental contaminants. Hock and Elstner, who between them have published over 500 original papers on plants and plant disease, called upon experts from across the world to contribute to this essential text. The book analyzes processes central to plant metabolism, including uptake, distribution, and secretion of toxic material, and focuses on the recognition and prevention of damage associated with environmental pollutants. It studies diseases caused by viruses, subviral organisms, phytoplasmas, fungal and bacterial pathogens. Learn about Pathology in Plants as an Integral Interconnected Facet of their Environment The text is designed to enable you to classify and target specific forms of plant damage. Equally important, it never loses sight of the princple that plants are not isolated organisms, but rather exist as participants in complex environments, which must be taken into account when studying the delivery and impact of toxins. Supplying more than 1500 current references, Plant Toxicology, Fourth Edition is required reading for all plant, crop, soil, and environmental scientists; botanists; agronomists; agriculturists; horticulturists; biochemists; foresters; plant growers; and upper level undergraduate and graduate students in these disciplines. Features |
Cardiotoxicity: Heart Damage from Cancer Treatment
Jun 20, 2022 · Cardiotoxicity refers to any heart damage arising from cancer treatment. It isn’t common overall but may be common in people who take certain chemotherapy or targeted …
Cardiotoxicity - Wikipedia
Cardiotoxicity is the occurrence of heart dysfunction as electric or muscle damage, resulting in heart toxicity. [1] . This can cause heart failure, arrhythmia, myocarditis, and cardiomyopathy …
Cardiovascular Toxicity Related to Cancer Treatment: A …
Sep 5, 2020 · In this statement, the experts addressed the cardiovascular monitoring strategies for the cancer drugs associated with the highest risk of cardiovascular toxicities, as well as the …
Cardiotoxicity of cancer chemotherapy agents other than ... - UpToDate
Aug 20, 2024 · Cancer patients receiving chemotherapy have an increased risk of developing cardiovascular complications, and the risk is even greater if there is a known history of heart …
Cardiotoxicity of chemotherapy and targeted agents - PMC
Cardiotoxicity can be defined in a variety of ways including diminished left ventricular ejection fraction (LVEF), damage to cardiac cells and structure, conduction abnormalities, vascular …
Chemotherapy Agents That Cause Cardiotoxicity - U.S. Pharmacist
Sep 15, 2017 · Cardiotoxicity, or medication-induced damage to the heart muscle—e.g., heart failure (HF), structural damage, and hypertension)— is a known adverse effect of many …
Cardiotoxicity: Causes, Symptoms, and Prevention
Cardiotoxicity is a condition resulting from the detrimental impact of certain substances or medications on the heart muscle. It manifests as a range of cardiovascular dysfunctions, from …
Cardiac Toxicity - OncoLink
Cardiac (heart) toxicity is a side effect of cancer treatment that causes damage to the heart muscle or valves. Both chemotherapy and radiation can lead to cardiac toxicity, based on the …
Cardiotoxicity | Division of Cancer Prevention
Researchers are investigating the health issues around cardiotoxicity, who is at risk, and how to reduce that risk. Common Data Elements for Cardio-Oncology Case Report Forms. Download …
Understanding Cardiotoxicity: Causes, Symptoms, and Prevention
Learn about the different types of cardiotoxic substances, their effects on the heart, and how to prevent cardiotoxicity when taking medications or using supplements.
Cardiotoxicity: Heart Damage from Cancer Treatment
Jun 20, 2022 · Cardiotoxicity refers to any heart damage arising from cancer treatment. It isn’t common overall but may be common in people who take certain chemotherapy or targeted …
Cardiotoxicity - Wikipedia
Cardiotoxicity is the occurrence of heart dysfunction as electric or muscle damage, resulting in heart toxicity. [1] . This can cause heart failure, arrhythmia, myocarditis, and cardiomyopathy …
Cardiovascular Toxicity Related to Cancer Treatment: A …
Sep 5, 2020 · In this statement, the experts addressed the cardiovascular monitoring strategies for the cancer drugs associated with the highest risk of cardiovascular toxicities, as well as the …
Cardiotoxicity of cancer chemotherapy agents other than ... - UpToDate
Aug 20, 2024 · Cancer patients receiving chemotherapy have an increased risk of developing cardiovascular complications, and the risk is even greater if there is a known history of heart …
Cardiotoxicity of chemotherapy and targeted agents - PMC
Cardiotoxicity can be defined in a variety of ways including diminished left ventricular ejection fraction (LVEF), damage to cardiac cells and structure, conduction abnormalities, vascular …
Chemotherapy Agents That Cause Cardiotoxicity - U.S. Pharmacist
Sep 15, 2017 · Cardiotoxicity, or medication-induced damage to the heart muscle—e.g., heart failure (HF), structural damage, and hypertension)— is a known adverse effect of many …
Cardiotoxicity: Causes, Symptoms, and Prevention
Cardiotoxicity is a condition resulting from the detrimental impact of certain substances or medications on the heart muscle. It manifests as a range of cardiovascular dysfunctions, from …
Cardiac Toxicity - OncoLink
Cardiac (heart) toxicity is a side effect of cancer treatment that causes damage to the heart muscle or valves. Both chemotherapy and radiation can lead to cardiac toxicity, based on the …
Cardiotoxicity | Division of Cancer Prevention
Researchers are investigating the health issues around cardiotoxicity, who is at risk, and how to reduce that risk. Common Data Elements for Cardio-Oncology Case Report Forms. Download …
Understanding Cardiotoxicity: Causes, Symptoms, and Prevention
Learn about the different types of cardiotoxic substances, their effects on the heart, and how to prevent cardiotoxicity when taking medications or using supplements.
